Cargando…
AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
BACKGROUND: Aldo-keto reductase family 1 member C3 (AKR1C3) is a key steroidogenic enzyme that is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). The aim of this study was to investigate the correlation between the express...
Autores principales: | Tian, Yuantong, Zhao, Lijing, Zhang, Haitao, Liu, Xichun, Zhao, Lijuan, Zhao, Xuejian, Li, Yi, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939640/ https://www.ncbi.nlm.nih.gov/pubmed/24571686 http://dx.doi.org/10.1186/1746-1596-9-42 |
Ejemplares similares
-
Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells
por: Tian, Yuantong, et al.
Publicado: (2016) -
Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition
por: Liu, Xichun, et al.
Publicado: (2010) -
Focal adhesion kinase is overexpressed in thymic epithelial tumors and may serve as an independent prognostic biomarker
por: Li, Meng, et al.
Publicado: (2018) -
siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro
por: Cui, Xiaoli, et al.
Publicado: (2022) -
AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
por: Zhao, Shou-Feng, et al.
Publicado: (2019)